Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Alzheimer dementia

With ginkgo biloba against pathogenic disease processes

    • Education
    • Geriatrics
    • Neurology
    • RX
  • 3 minute read

The most common form of dementia in the elderly – Alzheimer’s disease – is associated with amyloid plaques and Alzheimer’s fibrils. Both β-amyloid and p-tau are two pathogenic molecules that play a crucial role in the induction of the disease. It has now been shown that long-term treatment with Gingko biloba extract can significantly improve Alzheimer’s pathology.

Alzheimer’s dementia (AD) is a neurodegenerative disease in the course of which there is impairment of orientation, communication skills, autobiographical identity and alteration of personality traits. Neuropathological and neurochemical changes are characteristic, usually beginning insidiously and then developing slowly but steadily over a period of several years [1]. What exactly causes the degradation of nerve cells has not yet been fully elucidated. However, it is certain that the disease is pathologically characterized mainly by β-amyloid (Aβ) plaques and tau fibrils [2].

Aβ is a natural protein that arises from a precursor protein and is normally cleaved and degraded in the brain. As AD alters the degradation of amyloid precursor protein, increased Aβ-proteins are formed. These accumulate to form β-amyloid plaques, which are deposited between nerve cells and can no longer be broken down by the body [3]. Tau proteins are responsible for cell stability and nutrient supply. Chemical changes cause the protein to accumulate in the form of fibers – tau fibrils – in the nerve cell, causing them to lose their shape and function [3].

Key element detected?

Evidence suggests that oligomeric Aβ induces hyperphosphorylation and aggregation of tau and extends tau pathology from a limited region around the medial temporal cortex to the entire neocortex. Experiments have demonstrated that tau accumulation is associated with poorer cognitive performance and brain atrophy. In the cerebrospinal fluid of Alzheimer’s patients, the protein content of p-tau and the total amount of tau proteins are increased. How p-Tau affects the neuronal network is still unclear. However, different mechanisms are discussed:

  • Hyperphosphorylation of tau disrupts the normal function of tau in stabilizing the cytoskeleton and regulating axonal transport
  • Tau targets the tyrosine kinase Fyn and mediates Aβ-induced loss of the N-methyl-D-aspartate receptor at the postsynapse
  • Tau accumulation dephosphorylates cAMP response element binding protein (CREB), thereby impairing synaptic junction formation
  • p-Tau induces the accumulation of oligomeric insulin and insulin resistance in neurons

In any case, p-tau seems to be a key pathogenic molecule in AD and, accordingly, a reduction could halt the progression of the disease.

Autophagy – a pathway to lower p-tau levels?

There is growing evidence that macroautophagy may be an effective mechanism for reducing p-tau. In mice, p-tau was observed to accumulate in the brain when the major autophagic component (ATG7) was ablated in forebrain neurons. In addition, autophagy-promoting interventions lowered the protein level of cerebral p-tau. By enhancing neuronal autophagy via activation of chronic microglial inflammation, cerebral p-tau was reduced and cognitive deficit was attenuated [4]. Therefore, a study was conducted to investigate whether cerebral p-tau levels could be lowered by Ginkgo biloba extract EGb 761 and thus prevent AD pathogenesis. For this, human P301S tau mutant transgenic mice were fed EGb 761 added to the regular diet for two or five months.

Treatment with EGb 761 for five months was indeed able to significantly improve the cognitive function of the mice, attenuate the loss of synaptophysin, and restore the phosphorylation of CREB in the mouse brain. Also, the amount of p-tau protein was decreased and microglial pro-inflammatory activation was shifted to anti-inflammatory activation in the brain. However, this effect did not yet occur after the two-month therapy. Accordingly, long-term treatment with Ginkgo biloba extract EGb 761, a clinically available and well-tolerated herbal drug, improves Alzheimer’s pathology through mechanisms against multiple pathogenic processes of the disease.

 

Literature:

  1. https://neurotransconcept.com/indications/?i=DEM&p=2 (last accessed 08/17/2020)
  2. www.amboss.com/de/wissen/Morbus_Alzheimer (last accessed 08/17/2020)
  3. www.alzheimer-forschung.de/alzheimer/wasistalzheimer/veraenderungen-im-gehirn (last accessed 08/17/2020)
  4. Qin Y, Zhang Y, Tomic I, et al: Ginkgo biloba extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons. J Alzheimers Dis 2018; 65(1): 243-263.

 

InFo NEUROLOGY & PSYCHIATRY 2020; 18(5): 26.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Alzheimer
  • Dementia
  • Ginkgo
Previous Article
  • Behçet's disease

Apremilast approved for the treatment of oral aphthae

  • Dermatology and venereology
  • General Internal Medicine
  • Market & Medicine
  • ORL
  • Rheumatology
  • RX
  • Studies
View Post
Next Article
  • Atrial fibrillation

In practice more and more often

  • Cardiology
  • Education
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.